Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Introduction and aim. Hepatitis patients usually present with comorbidities and polypharmacy which increases risk of potential drug-drug interactions (pDDIs). We explored frequency, levels, predictors, and clinical relevance of pDDIs in hospitalized hepatitis patients.Material and methods. Retrospec...
Main Authors: | Sidra Noor, Mohammad Ismail, Iqbal Haider, Faiza Khadim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-11-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119310622 |
Similar Items
-
Potential drug–drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria
by: Sidra Noor, et al.
Published: (2020-08-01) -
Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
by: Sidra Noor, et al.
Published: (2019-07-01) -
Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
by: Mohammad Ismail, et al.
Published: (2020-04-01) -
Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety
by: Sidra Noor, et al.
Published: (2019-09-01) -
Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study
by: Mohammad Ismail, et al.
Published: (2018-10-01)